Video

What To Know About Aducanumab and Slowing the Progression of Alzheimer Disease

Pharmacy Times spoke to Dr. Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.

Pharmacy Times spoke to Dr.Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.

Related Videos
Alzheimer and dementia clock drawing cognitive test -- Image credit: Jovana Milanko/Stocksy | stock.adobe.com
Caregiver holding elderly man's hand -- Image credit: Chinnapong | stock.adobe.com
Health care worker looking at MRI scans of dementia -- Image credit: Atthapon | stock.adobe.com
Neurons in Alzheimer disease -- Image credit: Dr_Microbe | stock.adobe.com
Amyloid plaques in brain -- Image credit: Dr_Microbe | stock.adobe.com
Elderly man completing puzzle Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Pharmacy Times Public Health Matters Podcast (logo)
Therapy session -- Image credit: pressmaster | stock.adobe.com